Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
View Patent ↗The present invention provides selenium derivatives of nucleosides, nucleoside phosphoramidites, nucleotides, nucleotide triphosphates, oligonucleotides, polynucleotides, and larger nucleic acids and methods for their synthesis. Selenium derivatives of both ribonucleic acids and deoxyribonucleic acids, as well as methods for their synthesis, crystallization and uses in structural determinations, particularly by X-ray crystallographic techniques are disclosed. The selenium derivatives of the present invention are also useful as food supplements.
1. A selenium-containing compound having the structure of formula I:
wherein:
(a) R 1 is a nucleic acid base selected from the group consisting of cytosine and 2-selenocytosine; or is a protected nucleic acid base selected from the group consisting of protected cytosine and 2-selenocytosine;
(b) R 2 is H, HO, alkyl-O, TBDMS-O, TOM-O group, ACE-O group, orthoester group, diselenide, or alkyl-Se;
(c) R 3 is H, HO, alkyl-O, TBDMS-O, diselenide, alkyl-Se, phosphoramidite, phosphoroselenoamidite, phosphate, a 5′ linked nucleotide, a 5′ linked seleno-nucleotide, a 5′ linked oligonucleotide, a 5′linked seleno-oligonucleotide, a 5′ linked nucleic acid chain, or a 5′ linked seleno-nucleic acid chain, wherein any phosphorus atom of a bridging phosphate of the 5′ linked seleno-nucleotide, the 5′ linked seleno-oligonucleotide, or the 5′ linked seleno-nucleic acid chain is bonded to non-selenium atoms;
(d) R 4 is H, HO, HSe, diselenide, alkyl-Se, alkyl-O, DMTr-O, TBDMS-O, (alkyl-O) 3 Si—O, phosphate, diphosphate, diphosphoroselenoate, triphosphate, triphosphoroselenoate, a 3′ linked nucleotide, a 3′ linked seleno-nucleotide, a 3′ linked oligonucleotide, a 3′ linked seleno-oligonucleotide, a 3′ linked nucleic acid chain, or a 3′ linked seleno-nucleic acid chain, wherein any phosphorus atom of a bridging phosphate of the 3′ linked seleno-nucleotide, the 3′ linked seleno-oligonucleotide, or the 3′ linked seleno-nucleic acid chain is bonded to non-selenium atoms; and
(e) X is an oxygen atom or a selenium atom;
wherein at least one of R 1 , R 2 , or X comprises at least one selenium atom, and wherein alkyl is a saturated or unsaturated, branched or unbranched hydrocarbon group having between 1 and 24 carbon atoms.
2. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is a nucleic acid base selected from the group consisting of cytosine and 2-selenocytosine; or is a protected nucleic acid base selected from the group consisting of protected cytosine and 2-selenocytosine;
(b) R 2 is H, HO, alkyl-O, TBDMS-O, TOM-O group, ACE-O group, methyl-Se, ethyl-Se, or propyl-Se;
(c) R 3 is H, HO, alkyl-O, TBDMS-O, methyl-Se, ethyl-Se, propyl-Se, phosphoramidite, or phosphate;
(d) R 4 is H, HO, alkyl-O, DMTr-O, methyl-Se, ethyl-Se, propyl-Se, phosphate, diphosphate, diphosphoroselenoate, triphosphate, or triphosphoroselenoate; and
(e) X is an oxygen atom;
wherein at least one of R 1 or R 2 comprises at least one selenium atom.
3. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is a nucleic acid base selected from the group consisting of cytosine and 2-selenocytosine; or is a protected nucleic acid base selected from the group consisting of protected cytosine and 2-selenocytosine;
(b) R 2 is H, alkyl-O, TBDMS-O, TOM-O group, ACE-O group, methyl-Se, ethyl-Se, or propyl-Se;
(c) R 3 is phosphoramidite;
(d) R 4 is DMTr-O; and
(e) X is an oxygen atom;
wherein at least one of R 1 or R 2 comprises at least one selenium atom.
4. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is the nucleic acid base cytosine; or is a protected cytosine;
(b) R 2 is methyl-Se;
(c) R 3 is phosphoramidite;
(d) R 4 is DMTr-O, TBDMS-O, or (alkyl-O) 3 Si—O; and
(e) X is an oxygen atom.
5. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is a protected 2-selenocytosine;
(b) R 2 is H, alkyl-O, TBDMS-O, TOM-O group, or ACE-O group;
(c) R 3 is phosphoramidite;
(d) R 4 is DMTr-O; and
(e) X is an oxygen atom.
6. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is the nucleic acid base cytosine;
(b) R 2 is diselenide, or alkyl-Se;
(c) R 3 is HO or H;
(d) R 4 is HO or H; and
(e) X is an oxygen atom.
7. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is 2-selenocytosine;
(b) R 2 is HO or H;
(c) R 3 is HO or H;
(d) R 4 is HO or H; and
(e) X is an oxygen atom.
8. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is the nucleic acid base cytosine;
(b) R 2 is HO or H;
(c) R 3 is HO or H;
(d) R 4 is HO or H; and
(e) X is a selenium atom.
9. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is a nucleic acid base selected from cytosine and 2-selenocytosine;
(b) R 2 is H, HO, or methyl-Se;
(c) R 3 is H, HO, or methyl-Se;
(d) R 4 is phosphate, diphosphate, diphosphoroselenoate, triphosphate, or triphosphoroselenoate; and
(e) X is an oxygen atom;
wherein at least one of R 1 or R 2 comprises at least one selenium atom.
10. A selenium-containing compound according to claim 1 , wherein:
(a) R 1 is 2-selenocytosine;
(b) R 2 is H or HO;
(c) R 3 is HO;
(d) R 4 is triphosphate; and
(e) X is an oxygen atom.
11. A process for preparing a compound having the structure of formula I:
wherein:
(a) R 1 is a nucleic acid base selected from the group consisting of cytosine and 2-selenocytosine; or is a protected nucleic acid base selected from the group consisting of protected cytosine and 2-selenocytosine;
(b) R 2 is H, HO, alkyl-O, TBDMS-O, TOM-O group, ACE-O group, orthoester group, diselenide, alkyl-Se, or Z 1 ;
(c) R 3 is H, HO, alkyl-O, TBDMS-O, diselenide, alkyl-Se, phosphoramidite, phosphoroselenoamidite, phosphate, a 5′ linked nucleotide, a 5′ linked seleno-nucleotide, a 5′ linked oligonucleotide, a 5′ linked seleno-oligonucleotide, a 5′ linked nucleic acid chain, a 5′ linked seleno-nucleic acid chain, or Z 2 , wherein any phosphorus atom of a bridging phosphate of the 5′ linked seleno-nucleotide, the 5′ linked seleno-oligonucleotide, or the 5′ linked seleno-nucleic acid chain is bonded to non-selenium atoms;
(d) R 4 is H, HO, HSe, diselenide, alkyl-Se, alkyl-O, DMTr-O, TBDMS-O, (alkyl-O) 3 Si—O, phosphate, diphosphate, diphosphoroselenoate, triphosphate, triphosphoroselenoate, a 3′ linked nucleotide, a 3′ linked seleno-nucleotide, a 3′ linked oligonucleotide, a 3′ linked seleno-oligonucleotide, a 3′ linked nucleic acid chain, a 3′ linked seleno-nucleic acid chain, or Z 3 , wherein any phosphorus atom of a bridging phosphate of the 3′ linked seleno-nucleotide, the 3′ linked seleno-oligonucleotide, or the 3′ linked seleno-nucleic acid chain is bonded to non-selenium atoms; and
(e) X is an oxygen atom or a selenium atom;
wherein at least one of R 1 , R 2 , or X comprises at least one selenium atom; and wherein Z 1 , Z 2 , or Z 3 is diselenide, alkyl-Se, or phosphoroselenoamidite; wherein alkyl is a saturated or unsaturated, branched or unbranched hydrocarbon group having between 1 and 24 carbon atoms;
and wherein at least one of R 2 , R 3 , or R 4 is Z 1 , Z 2 , or Z 3 ;
the process comprising:
providing a precursor, the precursor having the structure of the compound except that Z 1 , Z 2 , or Z 3 is a leaving group; and reacting the precursor with a selenide ion, a diselenide ion, or an alkyl selenide ion; wherein the reaction occurs in a two phase system comprising a water-immiscible organic phase and an aqueous phase in the presence of a phase transfer catalyst, wherein the phase transfer catalyst causes selenide ion or alkyl selenide ion transfer between the water-immiscible organic phase and the aqueous phase; or in one phase of an organic solvent, or a mix of solvents.
12. A process according to claim 11 , wherein:
(a) R 1 is a nucleic acid base selected from the group consisting of cytosine and 2-selenocytosine; or is a protected nucleic acid base selected from the group consisting of protected cytosine and 2-selenocytosine;
(b) R 2 is H, HO, alkyl-O, TBDMS-O, TOM-O group, ACE-O group, methyl-Se, ethyl-Se, or propyl-Se;
(c) R 3 is H, HO, alkyl-O, TBDMS-O, methyl-Se, ethyl-Se, propyl-Se, phosphoramidite, or phosphate;
(d) R 4 is H, HO, alkyl-O, DMTr-O, methyl-Se, ethyl-Se, propyl-Se, phosphate, diphosphate, diphosphoroselenoate, triphosphate, or triphosphoroselenoate; and
(e) X is an oxygen atom;
wherein at least one of R 1 , or R 2 comprises at least one selenium atom.
13. A process according to claim 11 , wherein:
(a) R 1 is a nucleic acid base selected from the group consisting of cytosine and 2-selenocytosine; or is a protected nucleic acid base selected from the group consisting of protected cytosine and 2-selenocytosine;
(b) R 2 is H, alkyl-O, TBDMS-O, TOM-O group, ACE-O group, methyl-Se, ethyl-Se, or propyl-Se;
(c) R 3 is phosphoramidite;
(d) R 4 is DMTr-O; and
(e) X is an oxygen atom;
wherein at least one of R 1 or R 2 comprises at least one selenium atom.
14. A process according to claim 11 , wherein the water immiscible organic phase comprises toluene, benzene, or hexane.
15. A process according to claim 11 , wherein the phase transfer catalyst comprises a quaternary ammonium ion and a counterion.
16. A process according to claim 11 , wherein the phase transfer catalyst comprises a quaternary ammonium ion and a counterion selected from the group consisting of F − , Cl − , Br − , I − ClO 3 − , NO 3 − , HCO 3 − , and HSO 4 − .
17. A process according to claim 11 , wherein an organic solvent for one phase reaction is ethanol, DMF, acetonitrile, or a mix of solvents.